Sanjay Agrawal, a scientific advisor at US-based Alkomex GBN Pharma Group, has developed an anti-ageing drug formulation targeting ageing at a cellular level. The formulation promises improvements in skin health and vitality. Agrawal has applied for a patent in India, highlighting the drug’s potential to revolutionize anti-ageing medicine
